Li B - Search Results

1

Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.

Li B, Russell SJ, Compaan DM, Totpal K, Marsters SA, Ashkenazi A, Cochran AG, Hymowitz SG, Sidhu SS. Li B, et al. J Mol Biol. 2006 Aug 18;361(3):522-36. doi: 10.1016/j.jmb.2006.06.042. Epub 2006 Jul 7. J Mol Biol. 2006. PMID: 16859704

2

Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.

Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ. Pan B, et al. Among authors: li b. J Mol Biol. 2002 Feb 22;316(3):769-87. doi: 10.1006/jmbi.2001.5370. J Mol Biol. 2002. PMID: 11866530

3

Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.

Sidhu SS, Li B, Chen Y, Fellouse FA, Eigenbrot C, Fuh G. Sidhu SS, et al. Among authors: li b. J Mol Biol. 2004 Apr 23;338(2):299-310. doi: 10.1016/j.jmb.2004.02.050. J Mol Biol. 2004. PMID: 15066433

4

Molecular recognition by a binary code.

Fellouse FA, Li B, Compaan DM, Peden AA, Hymowitz SG, Sidhu SS. Fellouse FA, et al. Among authors: li b. J Mol Biol. 2005 May 20;348(5):1153-62. doi: 10.1016/j.jmb.2005.03.041. Epub 2005 Apr 1. J Mol Biol. 2005. PMID: 15854651

5

Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.

Li B, Xi H, Diehl L, Lee WP, Sturgeon L, Chinn J, Deforge L, Kelley RF, Wiesmann C, van Lookeren Campagne M, Sidhu SS. Li B, et al. J Biol Chem. 2009 Dec 18;284(51):35605-11. doi: 10.1074/jbc.M109.035170. J Biol Chem. 2009. PMID: 19833734 Free PMC article.

6

Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.

Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB. Chen Y, et al. Among authors: li b. J Mol Biol. 1999 Nov 5;293(4):865-81. doi: 10.1006/jmbi.1999.3192. J Mol Biol. 1999. PMID: 10543973

7

VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.

Muller YA, Chen Y, Christinger HW, Li B, Cunningham BC, Lowman HB, de Vos AM. Muller YA, et al. Among authors: li b. Structure. 1998 Sep 15;6(9):1153-67. doi: 10.1016/s0969-2126(98)00116-6. Structure. 1998. PMID: 9753694 Free article.

8

Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge.

Li B, Tesar D, Boswell CA, Cahaya HS, Wong A, Zhang J, Meng YG, Eigenbrot C, Pantua H, Diao J, Kapadia SB, Deng R, Kelley RF. Li B, et al. MAbs. 2014;6(5):1255-64. doi: 10.4161/mabs.29809. Epub 2014 Oct 30. MAbs. 2014. PMID: 25517310 Free PMC article.

9

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG. Shields RL, et al. Among authors: li b. J Biol Chem. 2001 Mar 2;276(9):6591-604. doi: 10.1074/jbc.M009483200. Epub 2000 Nov 28. J Biol Chem. 2001. PMID: 11096108 Free article.

10

Development and preclinical characterization of a humanized antibody targeting CXCL12.

Zhong C, Wang J, Li B, Xiang H, Ultsch M, Coons M, Wong T, Chiang NY, Clark S, Clark R, Quintana L, Gribling P, Suto E, Barck K, Corpuz R, Yao J, Takkar R, Lee WP, Damico-Beyer LA, Carano RD, Adams C, Kelley RF, Wang W, Ferrara N. Zhong C, et al. Among authors: li b. Clin Cancer Res. 2013 Aug 15;19(16):4433-45. doi: 10.1158/1078-0432.CCR-13-0943. Epub 2013 Jun 28. Clin Cancer Res. 2013. PMID: 23812669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,548 results

Search Page

Filters